Takeda's Entyvio Label Expansion for Children Under FDA Review
Takeda's application for an expanded label for its drug Entyvio, to include use in children, is currently under review by the FDA.
Results for "Entyvio"
2 stories found
Alvotech Shares Rise on FDA Acceptance of Entyvio Biosimilar Application
Alvotech shares jumped after the U.S. Food and Drug Administration (FDA) accepted its Biologics License Application (BLA) for a biosimilar to Entyvio for review. This development marks a significant step for Alvotech in bringing its biosimilar to market.